Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Capital Expenditure Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Cash spent on acquiring or upgrading physical assets
Latest
$-297.70M
↓ 67% below average
Average (9y)
$-178.79M
Historical baseline
Range
High:$-45.30M
Low:$-297.70M
CAGR
+23.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-297.70M | -15.2% |
| 2023 | $-258.40M | -26.2% |
| 2022 | $-204.70M | +12.9% |
| 2021 | $-235.00M | +9.5% |
| 2020 | $-259.80M | -244.3% |
| 2019 | $-75.45M | +21.0% |
| 2018 | $-95.52M | +63.2% |
| 2017 | $-259.42M | -358.6% |
| 2016 | $-56.56M | -24.9% |
| 2015 | $-45.30M | - |